Expand NTLA Menu
NTLA MENU

NTLA Stock Summary and Trading Ideas (Intellia Therapeutics | NASDAQ:NTLA)

Charts for Today's Stock Price and Implied Volatility in Intellia Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for NTLA by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Intellia Therapeutics (NTLA) Frequently Asked Questions

What does Intellia Therapeutics do?

Intellia Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

What symbol and exchange does Intellia Therapeutics stock trade?

Intellia Therapeutics trades on the NASDAQ stock market under the symbol NTLA.

What is Intellia Therapeutics stock price doing today?

As of May 8, 2024, NTLA stock price declined to $22.94 with 943,925 million shares trading.

What is Intellia Therapeutics's Beta?

NTLA has a beta of 2.74, meaning it tends to be more sensitive to market movements. NTLA has a correlation of 0.29 to the broad based SPY ETF.

How much is Intellia Therapeutics worth?

NTLA has a market cap of $2.21 billion. This is considered a Mid Cap stock.

What is the highest and lowest price Intellia Therapeutics traded in the last 3 year period?

In the last 3 years, NTLA stock traded as high as $202.73 and as low as $19.37.

What are the top ETFs holding Intellia Therapeutics?

The top ETF exchange traded funds that NTLA belongs to (by Net Assets): ARKK, VTI, VB, XBI, ARKG.

Is Intellia Therapeutics (NTLA) a good investment?

NTLA has underperformed the market in the last year with a return of -47.7%, while the SPY ETF gained +27.0%. In the last 3 month period, NTLA fell short of the market, returning -12.0%, while SPY returned +4.2%. However, in the most recent 2 weeks NTLA has outperformed the stock market by returning +6.5%, while SPY returned +2.3%.

What is the support and resistance for Intellia Therapeutics (NTLA) stock price?

NTLA support price is $23.02 and resistance is $24.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NTLA stock will trade within this expected range on the day.